Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...